Home/Pipeline/Généthon Partnership for AAV Production

Généthon Partnership for AAV Production

Gene Therapy Vector Manufacturing

DevelopmentActive

Key Facts

Indication
Gene Therapy Vector Manufacturing
Phase
Development
Status
Active
Company

About Samabriva

Samabriva is a private, pre-revenue biotechnology company founded in 2011, headquartered in Paris and Amiens, France, with a biomanufacturing facility in Liège, Belgium. The company has developed a unique, patented bioproduction platform based on plant hairy root cultures grown in bioreactors, enabling the contained, year-round production of complex biomolecules. Operating primarily as a platform and service provider (CDMO/CFO model), Samabriva targets pharmaceutical and biotech clients seeking to outsource the production of plant-derived active ingredients, recombinant proteins, and virus-like particles (VLPs) with greater supply chain control and a reduced environmental footprint. Recent milestones include opening a new production facility and forming strategic partnerships, such as with Généthon for AAV vector production.

View full company profile